Cellares has unveiled strategic technology partnerships to enhance its Cell Q platform, an automated quality control system tailored for commercial-scale cell therapy manufacturing. This modular platform integrates solutions across liquid handling, flow cytometry, and sample tracking to automate labor-intensive QC assays, targeting throughput of up to 6,000 batches annually. Partners include Tecan, Cytek Biosciences, and others. Cell Q’s adoption is positioned to address scaling challenges in cell therapy production, improving consistency and reducing error risks in QC processes.